Hukui Bio

Hukui Biotechnology, founded in 2013, specializes in providing advanced medical technologies and innovative solutions, focusing on telemedicine and AI medical devices. The company serves a diverse range of clients, including medical electronics brands and healthcare providers, primarily in international markets. Hukui's core offerings include Medical AI Devices for Senior Care, Medical Images Endoscopy, and Point of Care Technologies, which provide comprehensive and efficient technical support to the medical industry.

Hukui facilitates market entry into China through its Guan Rong Project, which attracts overseas companies and enables smooth market access via its NMPA licensed facility in Chongqing, China. Additionally, the company operates a QMS certified facility in Hsinchu, Taiwan, extending CDMO (Contract Development and Manufacturing Organization) services worldwide. These services encompass product development, regulatory compliance, and sales distribution, ensuring meticulous manufacturing processes and punctual delivery to all customers.

Hukui's business model revolves around transforming groundbreaking product technologies into fully engineered solutions, seamlessly integrating clients with an elite network of suppliers. The company generates revenue through its comprehensive service offerings, including engineering, manufacturing, and consulting services for medical devices.

Keywords: telemedicine, AI medical devices, senior care, endoscopy, point of care, CDMO, regulatory compliance, market entry, NMPA license, QMS certified.